Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 9 studies | 41% ± 21% | |
oligodendrocyte precursor cell | 6 studies | 29% ± 11% | |
epithelial cell | 4 studies | 38% ± 8% | |
luminal hormone-sensing cell of mammary gland | 4 studies | 34% ± 8% | |
connective tissue cell | 3 studies | 47% ± 22% |
Insufficient scRNA-seq data for expression of BAMBI at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 665.90 | 225 / 226 | 75% | 56.97 | 303 / 406 |
kidney | 100% | 1375.44 | 89 / 89 | 73% | 59.84 | 655 / 901 |
brain | 95% | 740.50 | 2522 / 2642 | 72% | 27.49 | 505 / 705 |
breast | 78% | 688.74 | 359 / 459 | 87% | 152.02 | 972 / 1118 |
bladder | 100% | 3033.71 | 21 / 21 | 63% | 84.24 | 316 / 504 |
skin | 63% | 371.73 | 1139 / 1809 | 95% | 171.35 | 448 / 472 |
prostate | 82% | 436.95 | 202 / 245 | 70% | 34.07 | 352 / 502 |
lung | 100% | 1203.72 | 577 / 578 | 50% | 34.38 | 581 / 1155 |
uterus | 98% | 1628.94 | 166 / 170 | 46% | 35.82 | 211 / 459 |
pancreas | 70% | 225.27 | 229 / 328 | 67% | 36.06 | 119 / 178 |
adrenal gland | 100% | 3025.20 | 258 / 258 | 33% | 41.14 | 77 / 230 |
intestine | 63% | 209.42 | 606 / 966 | 57% | 35.76 | 302 / 527 |
ovary | 100% | 5080.29 | 180 / 180 | 13% | 5.96 | 56 / 430 |
esophagus | 60% | 203.20 | 864 / 1445 | 50% | 32.55 | 91 / 183 |
eye | 0% | 0 | 0 / 0 | 100% | 156.48 | 80 / 80 |
spleen | 100% | 1868.79 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 103.04 | 1 / 1 |
blood vessel | 97% | 1219.12 | 1298 / 1335 | 0% | 0 | 0 / 0 |
heart | 96% | 1997.96 | 828 / 861 | 0% | 0 | 0 / 0 |
stomach | 50% | 179.06 | 181 / 359 | 44% | 38.33 | 127 / 286 |
adipose | 70% | 283.10 | 842 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 31% | 10.81 | 14 / 45 |
thymus | 25% | 63.04 | 163 / 653 | 2% | 0.86 | 14 / 605 |
muscle | 6% | 13.73 | 48 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 4% | 10.52 | 34 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.63 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010718 | Biological process | positive regulation of epithelial to mesenchymal transition |
GO_0032092 | Biological process | positive regulation of protein binding |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0008360 | Biological process | regulation of cell shape |
GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0030514 | Biological process | negative regulation of BMP signaling pathway |
GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
GO_0030512 | Biological process | negative regulation of transforming growth factor beta receptor signaling pathway |
GO_0016477 | Biological process | cell migration |
GO_0045668 | Biological process | negative regulation of osteoblast differentiation |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005109 | Molecular function | frizzled binding |
GO_0005515 | Molecular function | protein binding |
GO_0005114 | Molecular function | type II transforming growth factor beta receptor binding |
Gene name | BAMBI |
Protein name | BMP and activin membrane-bound inhibitor homolog (Non-metastatic gene A protein) (Putative transmembrane protein NMA) |
Synonyms | NMA |
Description | FUNCTION: Negatively regulates TGF-beta signaling. |
Accessions | ENST00000375533.6 Q13145 |